CNIO finds a possible new pharmacological target for one of the most important and elusive oncogenes

The MYC oncogene intervenes in many types of cancer, some of which are very aggressive; researchers suspect that controlling its activity could open avenues to new treatments.

Be the first to comment

Leave a Reply

Your email address will not be published.